Font Size: a A A
Keyword [major adverse cardiac events]
Result: 21 - 40 | Page: 2 of 6
21. Intracoronary Stenting Myocardial Fractional Flow Reserve To Predict Cardiac Events
22. Effects Of Loading Dose Of Atorvastatin Before Percutaneous Coronary Intervention On Periprocedural Myocardial Injury
23. The Clinical Significance And Influencing Factors Of Pericardial Effusion In Patients With Acute ST-segment Elevation Myocardial Infarction
24. Evaluation Of Cardiac Function After Percutaneous Coronary Intervention Of Chronic Total Occlusion Of Coronary Artery(CTO)
25. Medium-term Clinical Efficacy Of Loading-dose Atorvastatin Before Emergengcy Percutaneous Coronary Intervention In Patients With ST Elevation Myocardial Infarction
26. Meta-analysis:Loading Dose Statins Administered Before Percutaneous Coronary Intervention In Reducing30-day Major Adverse Cardiac Events In Patients With Coronary Atherosclerotic Heart Disease
27. Long-term Clinical Efficacy Of Loading-dose Atorvastatin Before Emergengcy Percutaneous Coronary Intervention In Patients With ST Elevation Myocardial Infarction
28. The Efficacy And Safety Of Domestic Bivalirudin In Patients With ST-segment Elevation Myocardial Infarction Underging Transradial Primary PCI
29. Clinical Evaluation With Fractional Flow Reserve Guiding On Percutaneous Coronary Intervention In Patients With Coronary Borderline Lesion
30. Outcome Analysis Of Left Main Coronary Artery Disease Treated By Percutaneous Coronary Intervention Or Coronary Artery Bypass Grafting
31. Association Between Serum Cardiac Troponin I And Cardiac Structure/Function And Its Inlfuence On The Prognosis In Patients With Chronic Heart Failure
32. Association Of PON1Genetic And Epigenetic Variation With The Clinical Efficacy Of Dual-antiplatelet Therapy
33. Interventional Treatment Of Unprotecte Left Main Coronary Artery Of Clinical Efficacy Observation
34. Evaluate The Prediction Of Major Adverse Cardiac Events With The Presence Of Anemia On Admission And The GRACE Risk Score The Prediction For In Patients With Acute Coronary Syndrome
35. The Relationship Between Plasma Circulating MicroRNAs And Major Adverse Cardiac Events After PCI
36. Reduction Of Complication In ACS Patients After PCI Within30Days By Triple Anti-platelet Therapy
37. Coronary CT Follow-up Study Of Acute Coronary Events
38. The Change Of CTnI And NT-proBNP For ACS Patients After PCI And Its Predictive Value Of MACE
39. Comparison Of Outcomes For Acute Myocardial Infarction In Elderly People Over75Years: With And Without Percutaneous Coronary Intervention
40. Usefulness Of The Index Of Microcirculatory Resistance For Assessing Short-term Clinical Outcome After Percutaneous Coronary Intervention For Sub-acute Myocardial Infarction
  <<First  <Prev  Next>  Last>>  Jump to